%PDF-1.7 % 13 0 obj << /Type /Page /Parent 1 0 R /LastModified (D:20190921004231-04'00') /Resources 2 0 R /MediaBox [0.000000 0.000000 595.276000 841.890000] /CropBox [0.000000 0.000000 595.276000 841.890000] /BleedBox [0.000000 0.000000 595.276000 841.890000] /TrimBox [0.000000 0.000000 595.276000 841.890000] /ArtBox [0.000000 0.000000 595.276000 841.890000] /Contents 14 0 R /Rotate 0 /Group << /Type /Group /S /Transparency /CS /DeviceRGB >> /Annots [ 6 0 R 7 0 R 8 0 R 9 0 R ] /PZ 1 >> endobj 14 0 obj <> stream x\]s۶}S;#3$GiL3i$.Ҕ,'LNdk$Q],{qlWx x{ٓKxCA.W̿;;J[QP4g< |/K4/A!9Swdx;#cǶhzq'Y ixq]wOنgW M'y r p+UǙ ._*" `z^VB!lyHIf!ҦjּAQF|Ι~\*'G݁L"/<39<o0>B?8~6;8$8, o5/NMfu=Lif.WY}M㝎mvjvUh$9,rU9r׬&"vUُ_-_#_s(`N,Shv^Flj!A]- ͊ɊBvhK P5*誓^|4˗翻0RZԢ.&9gc ,EVHF2+qO{j؛]J *^$dhaOġ,<5SKANoāA?4'@q`&yQ>hj 1[.YpZUlFi2+ Y;`]5E~z Lh_G̋Ð?6aus a`tga~lp81S'NKQ:[FYbьXNhC\,C/ɾհM3_&FkAK^3>1f^U'q9BE5oltm 5 ZYr3RY9tdzpYt]db*sĉbme>]3ٰ݇nV:HL.05o_f p4Q0X]*V`[?ڙy*׬9; \$1^3FWE!p} i]sjF[&k]Nۓ~aoL5Vo. ]NXSzaS9¥aZCJcwi`TZqhޅ9ıJMKZhx)]Dnj[3t܅4Oh[!N5MH4 tg%aJ3 h'-z %; ~@ e07ٟӜaE|oy<-|! endstream endobj 15 0 obj << /Type /Page /Parent 1 0 R /LastModified (D:20190921004231-04'00') /Resources 2 0 R /MediaBox [0.000000 0.000000 595.276000 841.890000] /CropBox [0.000000 0.000000 595.276000 841.890000] /BleedBox [0.000000 0.000000 595.276000 841.890000] /TrimBox [0.000000 0.000000 595.276000 841.890000] /ArtBox [0.000000 0.000000 595.276000 841.890000] /Contents 16 0 R /Rotate 0 /Group << /Type /Group /S /Transparency /CS /DeviceRGB >> /Annots [ 10 0 R 12 0 R ] /PZ 1 >> endobj 16 0 obj <> stream xVS0~_:#i <=o'=yB(q lg[\:i6o˲(\n'JF> X3wL"ຄv GHx^*>l,MWע\$`+pWnHΈpC$}S.K |ߣ0A#>Յ7!  I4cخ>#nN.O Q6JpW7VUTF?&5dȸe" T(K[ClQ(!l+34;.ZWרp$1Ǩ}T\nuDcD"_Q sZV2 xOi}(GsBs[[a!S-jDm9 Nbgbbߪiޙ悑0t[ H6S,C=pWV7'{tyB>QjHu2+0z6!ܨIn Tu9d2xIWl.Jc1V"[ s@9RE&ɏԋ|j ]A(9%6%XUB4 4FY+K)T]c&zKDZتgt9%.7Ugt/u# > endobj 3 0 obj <> endobj 5 0 obj <> endobj 11 0 obj <> endobj 17 0 obj <> stream JFIFHHExifMM* z(1>?QQ Q HHPaint.NET v3.5.10z%u0`:oCC." }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?(f 1T$`9Sw(B@;~(]Cd꾫Es:aݻd2\(2F][&]ۢϲ|W͵L@A A 8 (CĝCglZE/ |Ezє{ xQʒ@[ྊ\/I4R0?6.7`ŴwPu|3/Z@Ogi}cFdFKoj?~8|p_A<ĺOkGPK $wRmkmF;YVx&rLj#p ׭axf|s$Ӿc:Qwm]N)Cψ[eYba98xB+oTÚwcRþ$U[ ?qΙ{&jv6Xo$=ԗ&7zgAxIִ.$3,mwc{+%g[!U@&Fϻm/#hci'7n[%It.&/ֶ+Zl~:wi~D>$}o+}@.[/+B6mnt8bi{zc.~F{eUe86g3 VT&> BK VؘXzSMesoM_&ϔIÍK?+hڿnt_ K]H '̽yrWA=O+|"!gɤItXe>Xs hwwG Eouqa /ş_~~'x} ]_^]/ 蚼:<cu/ h&omEۯicǪ\[,k}_uS}㏆W]G^tmf`Ks ]=va&h9n忔>75NWQτ0of,E (˰8hBC_ Jq'W UQKz,N>+`S%}b5ISJ]+(&QVN>eoy7xG4[]]3K{i$I>g-(mbynLIC,"*3f?-%`lfPx涽X"H'h"ֈ(TfeU:܉,a,R*I4xcxalOhGр|ia$cg,{gAHEu->]F,{-.,EX"I$XQD/3R.{{T&ҭ%4[OPnx"HhM :e}-Լ'=s:\iZ<+Lj5+1AɮLZx-☽G3 1I"kuχ+A}5'NxI8 gJk[oenm!x,=n=>}kjPx~M񧍼5k45a,RLiȖTFQMR&K;}r+XkY[y>2F=2~6>Gmi++<[WF76MH4>;;Kf۽ъM3ZE}c㿈*- -.|G5uI![ YR$$A>Eyׇ|7u;n>4׭JϷR[h!rVr\{~Ϛ >0jMg?_y_ Do/x;ÚƏi a𶕦f|Eqgk4V^RY]}F,/J%ՌAud%:x3Hg_4[+^ ҴKaXF'n.]Z(i$bef5GO:u]/a~.3N4xiG*a8ާ-U){G nJEڿ[m7wv5MYp|'gm # #%B?|鿲w­{+_|Q#VkxcZޛ{I]Wyak}..i˨iY9QwOA~hf{+ |Y;cڴ27G>|H,na8o; CEO,ZLP?SHK} e92W7/1aj¤aڄq4 қS7,5]%EƔc/uҒw\r/EnT y>!V+VK4X^Y{;+Ӫ=MqslEn?Zz'Ë}^2xĺGf70/M~*DU=坍G{wwvci%vZ$GY&J9dkՀ\6hs.F*ĩ"+S%s*{ qqDj3$ q^T24,Cn +=j񟍼q5k'\%ݎ{ͦuyq4X$y<ك2Ey%™|Icw]3#R[`{KցY [1*kLOdw ^OAkЏb<¿ <=6x0ׄ>(=*[ t]9-?IZ@}/>FۃQ@ endstream endobj 4 0 obj << /Type /XObject /Subtype /Form /FormType 1 /Filter /FlateDecode /BBox [0.000000 0.000000 595.276000 76.535433] /Matrix [1 0 0 1 0 0] /Resources << /ProcSet [/PDF /Text /ImageB /ImageC /ImageI] /Font << /F2 5 0 R /F1 3 0 R >> /XObject << /I0 17 0 R >> >> /Length 197 >> stream xKkBA WeI&ڊU/ nʥBf8A3!(X4`JQj*Aj͕197f hkL[=µrw]F D%x2WC0 9)Z ^Wh}29yyu?4g=bT1߻a endstream endobj 2 0 obj << /ProcSet [/PDF /Text /ImageB /ImageC /ImageI] /Font << /F1 3 0 R /F2 5 0 R /F3 11 0 R >> /XObject << /XT4 4 0 R /I0 17 0 R >> >> endobj 6 0 obj <> /H /I>> endobj 7 0 obj <> /H /I>> endobj 8 0 obj <> /H /I>> endobj 9 0 obj <> /H /I>> endobj 10 0 obj <> /H /I>> endobj 12 0 obj <> /H /I>> endobj 18 0 obj << /Title (Capecitabine improved outcomes for breast cancer patients with disease after presurgery chemo) /Subject (Capecitabine improved outcomes for breast cancer patients with disease after presurgery chemo) /Creator (Science X Network) /Producer (TCPDF 6.2.25 \(http://www.tcpdf.org\)) /CreationDate (D:20190921004231-04'00') /ModDate (D:20190921004231-04'00') /Trapped /False >> endobj 19 0 obj << /Type /Metadata /Subtype /XML /Length 4427 >> stream application/pdf Capecitabine improved outcomes for breast cancer patients with disease after presurgery chemo Capecitabine improved outcomes for breast cancer patients with disease after presurgery chemo 2019-09-21T00:42:31-04:00 Science X Network 2019-09-21T00:42:31-04:00 2019-09-21T00:42:31-04:00 TCPDF 6.2.25 (http://www.tcpdf.org) uuid:460150e2-8492-5782-00f9-ddecaf4a4e6a uuid:460150e2-8492-5782-00f9-ddecaf4a4e6a http://ns.adobe.com/pdf/1.3/ pdf Adobe PDF Schema http://ns.adobe.com/xap/1.0/mm/ xmpMM XMP Media Management Schema internal UUID based identifier for specific incarnation of a document InstanceID URI http://www.aiim.org/pdfa/ns/id/ pdfaid PDF/A ID Schema internal Part of PDF/A standard part Integer internal Amendment of PDF/A standard amd Text internal Conformance level of PDF/A standard conformance Text endstream endobj 20 0 obj << /Type /Catalog /Version /1.7 /Pages 1 0 R /Names << >> /ViewerPreferences << /Direction /L2R >> /PageLayout /SinglePage /PageMode /UseNone /OpenAction [13 0 R /FitH null] /Metadata 19 0 R >> endobj xref 0 21 0000000000 65535 f 0000004505 00000 n 0000011041 00000 n 0000004572 00000 n 0000010540 00000 n 0000004678 00000 n 0000011188 00000 n 0000011431 00000 n 0000011690 00000 n 0000011941 00000 n 0000012190 00000 n 0000004789 00000 n 0000012482 00000 n 0000000015 00000 n 0000000503 00000 n 0000003192 00000 n 0000003670 00000 n 0000004904 00000 n 0000012700 00000 n 0000013346 00000 n 0000017856 00000 n trailer << /Size 21 /Root 20 0 R /Info 18 0 R /ID [ <460150e28492578200f9ddecaf4a4e6a> <460150e28492578200f9ddecaf4a4e6a> ] >> startxref 18066 %%EOF